85.90
Edwards Lifesciences Corp (EW) 最新ニュース
Decoding Edwards Lifesciences Corp (EW): A Strategic SWOT Insigh - GuruFocus
Edwards Lifesciences Hits Day High with Strong 3.33% Intraday Surge - Markets Mojo
Edwards Lifesciences Opens with 3.2% Gain, Outpacing S&P 500's 0.69% Increase - Markets Mojo
Edwards Lifesciences Stock Climbs 1.21% on Stronger Revenue, $0.35 Billion Trading Volume Ranks 387th for the Day - Bitget
Zacks Industry Outlook Highlights Intuitive Surgical, Edwards Lifesciences and Electromed - Yahoo Finance
NEW SURVEY BY EDWARDS LIFESCIENCES UNCOVERS JUST HOW MUCH AMERICANS KNOW ABOUT THEIR HEART HEALTH - Yahoo Finance
Daiwa Securities Adjusts Price Target on Edwards Lifesciences to $98 From $99, Maintains Buy Rating - marketscreener.com
Here is Why Edwards Lifesciences Corporation (EW) Looks Attractive - Insider Monkey
Edwards Lifesciences Corp (EW)'s Winning Formula: Financial Metr - GuruFocus
Equitable Trust Co. Sells 15,075 Shares of Edwards Lifesciences Corporation $EW - Defense World
Cardiac Valve Market 20262035 Major Key Players: Edwards - openPR.com
Edwards Lifesciences Stock at $78: Here’s the Analysts’ Bull Case Scenario - TIKR.com
ORBIMED Advisors Trims $125 Million Terns Stake After a Breakout Year, According to SEC Filing - The Motley Fool
Edwards Lifesciences to Present at the Barclays and Leerink Partners Global Healthcare Conferences - marketscreener.com
First National Bank of Omaha Purchases New Stake in Edwards Lifesciences Corporation $EW - MarketBeat
Alberta Investment Management Corp Buys Shares of 68,300 Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences advances smart surgery monitoring with completed SMART TRENDS study - MSN
Edwards Lifesciences Corporation $EW Holdings Raised by Vanguard Group Inc. - MarketBeat
Edwards Lifesciences (NYSE:EW) Trading Up 5.6%Here's Why - MarketBeat
Edwards Lifesciences Corp. Drops ‘Anti-Copycatting’ Policy Amid EU Probe - USA Herald
Edwards Sued In Chancery Over $300M Heart Valve Earn-Out - Law360
Edwards Lifesciences (EW) Rises as EU Antitrust Probe Ends - GuruFocus
Edwards Lifesciences (EW) Experiences Significant Price Surge - GuruFocus
European Commission ends Edwards antitrust probe after company withdraws anti-copycat policy - MassDevice
Edwards Lifesciences Corporation $EW Shares Sold by PNC Financial Services Group Inc. - MarketBeat
Edwards Lifesciences (NYSE:EW) Shows Institutional Concentration Trends Within The S&P 500 Today - Kalkine Media
Edwards Lifesciences Corporation (NYSE:EW) is a favorite amongst institutional investors who own 88% - Yahoo Finance
Tobam Has $5.22 Million Holdings in Edwards Lifesciences Corporation $EW - MarketBeat
EU Closes Antitrust Investigation Against US' Edwards Lifesciences - marketscreener.com
Edwards Lifesciences scraps anti-copycat policy, EU drops antitrust investigation - Reuters
Eu antitrust regulators close investigation into edwards lifesciences after company withdraws anti-copycat policy - marketscreener.com
Achy Breaky Heart: The FTC Blocks Edwards-JenaValve Aortic Device Deal - marketscreener.com
What’s the outlook for Edwards Lifesciences Corporation’s sectorQuarterly Growth Report & Fast Moving Stock Watchlists - mfd.ru
Edwards Lifesciences Corporation (EW) Draws Positive Analyst View After Q4 Update - Finviz
Envestnet Asset Management Inc. Cuts Stock Position in Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences completes key study on SAPIEN XT THV - MSN
Is Edwards Lifesciences Corporation stock a smart retirement pickPortfolio Value Summary & Free Accurate Trade Setup Notifications - mfd.ru
Edwards Lifesciences to Present at Citi’s 2026 Unplugged Medtech and Life Sciences Access Day - The AI Journal
Rhumbline Advisers Acquires 15,792 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Corporation (NYSE:EW) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
How Investors Are Reacting To Edwards Lifesciences (EW) 2026 Guidance After Profit Squeeze In 2025 - Yahoo Finance
Halper Sadeh LLC Encourages Edwards Lifesciences - GlobeNewswire
Edwards Lifesciences Corporation $EW Shares Bought by Oppenheimer Asset Management Inc. - MarketBeat
Wells Fargo Raises Price Target for Edwards Lifesciences (EW) | - GuruFocus
Edwards Lifesciences Leans Into Growth After Strong Quarter - TipRanks
Edwards Lifesciences (EW): Truist Securities Maintains Hold Rati - GuruFocus
Edwards Lifesciences (EW) Analyst Ratings Update: Price Target L - GuruFocus
Edwards Lifesciences (NYSE:EW) Advances Structural Heart Solutions - Kalkine Media
Edwards Lifesciences Corp (NYSE:EW) Issues Upbeat Guidance - FXDailyReport.Com
Rothschild & Co Redburn Adjusts Edwards Lifesciences PT to $94 From $93, Maintains Buy Rating - marketscreener.com
Edwards Lifesciences 2026 Growth Targets Achievable, RBC Says - marketscreener.com
Piper Sandler Raises Price Target for Edwards Lifesciences (EW) to $100 | EW Stock News - GuruFocus
Edwards focuses on earlier TAVR adoption - MedTech Dive
Stifel reiterates Buy rating on Edwards Lifesciences stock at $110 target - Investing.com
Wells Fargo Raises Price Target for Edwards Lifesciences (EW) | EW Stock News - GuruFocus
Truist Securities Adjusts Price Target on Edwards Lifesciences to $89 From $92, Maintains Hold Rating - marketscreener.com
Wells Fargo & Company Raises Edwards Lifesciences (NYSE:EW) Price Target to $100.00 - MarketBeat
Edwards Lifesciences Corporation (NYSE:EW) Q4 2025 Earnings Call Transcript - Insider Monkey
Wells Fargo Adjusts Price Target on Edwards Lifesciences to $100 From $96, Maintains Overweight Rating - marketscreener.com
Leerink Partners Adjusts Price Target on Edwards Lifesciences to $87 From $88, Maintains Market Perform Rating - marketscreener.com
Baird Adjusts Price Target on Edwards Lifesciences to $87 From $90, Maintains Neutral Rating - marketscreener.com
大文字化:
|
ボリューム (24 時間):